Remove Chemotherapy Remove Clinic Management Remove Hospitals
article thumbnail

Reinventing Transplant Care: From Inpatient Tradition to Outpatient Innovation

Pharmacy Times

In an interview with Pharmacy Times , LeAnne Kennedy, PharmD, BCOP, CPP, FHOPA, oncology clinical manager at Atrium Health Wake Forest Baptist in Winston-Salem, North Carolina, highlights the extensive role of pharmacists in the Wake Outpatient Transplant program. Well, this is an outpatient unit.

article thumbnail

The evolution of durvalumab in NSCLC care

Hospital Pharmacy Europe

Durvalumab is ‘promising step forward’ The latest approval from the MHRA is based on positive data from the AEGEAN Phase III trial in rNSCLC , which showed that durvalumab-based treatment before and after surgery reduced the risk of recurrence, progression events or death by 32% versus neoadjuvant chemotherapy alone.

article thumbnail

Daily steps AI model able to predict unplanned hospitalisation during chemo-radiation

Hospital Pharmacy Europe

In fact, such unplanned visits are not uncommon and in one study of 402 study participants, 20% experienced an ED visit, and 18% experienced a hospital admission while receiving cancer treatment. The potential consequences of these visits might include interruption of chemotherapy, and this may impact on cancer therapy outcomes.